Medacta Group SA Market Cap ($2.97 Billion)
Market Cap & Net Worth: Medacta Group SA (MOVE)
Medacta Group SA market cap. Medacta Group SA (SW:MOVE) has a market capitalization of $2.97 Billion (CHF2.35 Billion) as of November 1, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #4774 globally and #76 in its home market, demonstrating a -1.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medacta Group SA's stock price CHF117.60 by its total outstanding shares 19944514 (19.94 Million). Also see MOVE cash flow metrics for how efficiently the company converts equity into cash flow.
Medacta Group SA Market Cap History (2019–2026)
Medacta Group SA market cap history from 2019 to 2026. Data shows growth from $1.80 Billion to $2.97 Billion (2.86% CAGR). Check MOVE live share price for real-time trading data and today's change.
Medacta Group SA Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medacta Group SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Medacta Group SA growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.55x
Medacta Group SA's market cap is 4.55 times its annual revenue
Latest Price to Earnings (P/E) Ratio
36.88x
Medacta Group SA's market cap is 36.88 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.80 Billion | $310.62 Million | $11.86 Million | 5.81x | 152.10x |
| 2020 | $2.18 Billion | $302.49 Million | $37.09 Million | 7.21x | 58.84x |
| 2021 | $3.54 Billion | $363.13 Million | $51.52 Million | 9.74x | 68.66x |
| 2022 | $2.58 Billion | $437.12 Million | $46.25 Million | 5.90x | 55.77x |
| 2023 | $3.15 Billion | $510.78 Million | $47.36 Million | 6.17x | 66.55x |
| 2024 | $2.69 Billion | $590.58 Million | $72.89 Million | 4.55x | 36.88x |
Competitor Companies of MOVE by Market Capitalization
Companies near Medacta Group SA in the global market cap rankings as of November 1, 2026. Also see MOVE total asset value for a full breakdown of the balance sheet.
Key companies related to Medacta Group SA by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #241 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $96.54 |
| #241 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Medacta Group SA (2019–2026)
Market capitalization of Medacta Group SA from 2019 to today. Between 2019 and today, Medacta Group SA's market cap moved from $1.80 Billion to $ 2.97 Billion, with a yearly change of 2.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF2.97 Billion | -24.81% |
| 2025 | CHF3.94 Billion | +46.72% |
| 2024 | CHF2.69 Billion | -14.72% |
| 2023 | CHF3.15 Billion | +22.21% |
| 2022 | CHF2.58 Billion | -27.09% |
| 2021 | CHF3.54 Billion | +62.10% |
| 2020 | CHF2.18 Billion | +20.99% |
| 2019 | CHF1.80 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Medacta Group SA was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.97 Billion USD |
| MoneyControl | $2.97 Billion USD |
| MarketWatch | $2.97 Billion USD |
| marketcap.company | $2.97 Billion USD |
| Reuters | $2.97 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.